2.5(top 7%)
Impact Factor
2.8(top 7%)
extended IF
112(top 3%)
H-Index
2.7K
authors
7K
papers
130.2K
citations
8.1K
citing journals
61.4K
citing authors
Institutions
Institution | Articles | Citations | A Rank | C Rank |
---|---|---|---|---|
Eli Lilly and Company | 215 | 4.6K | 5 | 33 |
Analysis Group | 158 | 2.8K | 2 | 2 |
Pfizer | 146 | 2.3K | 20 | 57 |
Novartis | 141 | 3.1K | 7 | 27 |
University of California | 105 | 1.8K | 255 | 255 |
GlaxoSmithKline | 89 | 2.3K | 34 | 90 |
Merck & Co. | 86 | 2.9K | 30 | 70 |
Princeton University | 77 | 1.7K | 255 | 255 |
Amgen | 74 | 1.4K | 18 | 79 |
AstraZeneca | 66 | 1.4K | 34 | 76 |
Research Triangle Park Foundation | 66 | 1.2K | 128 | 255 |
Aristotle University of Thessaloniki | 61 | 1.6K | 87 | 90 |
UCL Medical School | 59 | 1.6K | 56 | 112 |
University of Toronto | 54 | 1.1K | 255 | 255 |
University College London | 51 | 974 | 255 | 255 |
Duke University Hospital | 48 | 1.8K | 255 | 255 |
Novo Nordisk | 47 | 1.2K | 18 | 31 |
Sapienza University of Rome | 43 | 695 | 255 | 255 |
Sanofi | 42 | 897 | 16 | 48 |
Cleveland Clinic | 41 | 1K | 255 | 255 |